Large-scale testing (Phase 3)Study completedNCT00487435
What this trial is testing
An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
Who this might be right for
PainOsteoarthritisLow Back Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,166